The dysregulated inflammatory responses measured using plasma cytokine concentrations appear different between COVID-19 and CAP, with COVID-19 patients showing higher levels of IP-10, IL-10, and IL-6, and CAP patients had higher levels of GM-CSF. This evidence concerns the gene CXCL10 and COVID-19.